Today, the Canadian Centre for Policy Alternatives (CCPA) released a report that examines the effects of the Trans-Pacific Partnership (TPP) on the Canadian public health care system.
Author Scott Sinclair finds that the TPP investor protections would make it more difficult and costly for Canadian governments to establish new public health programs, including pharmacare, which is on the agenda of ongoing federal-provincial health talks.
The overarching impacts of the proposed treaty would be to weaken the Canadian public health care system, undermine health regulation, and obstruct efforts to renew and expand public health care in the face of new challenges.